The University of South Florida uses 3D printing to enhance dry eye disease research by mimicking the curvature of the cornea ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

In this Healio Video Perspective from the ASCRS meeting, Marguerite B. McDonald, MD, discusses the efficacy of Miebo for dry ...

Pregnant women may experience many physiological changes, including in the eyes. But most changes are minor, and resolve after childbirth.

Is prolonged sun exposure putting your eye health in danger? Here are some potential risks to consider and what you can do to ...

Urcosimod phase 2 trial treating Neuropathic Corneal Pain ("NCP”) patients was initiated in October 2024 and designed as a ...

Urcosimod is a lipid conjugated ChemR23 chemerin peptide agonist that is designed to reduce inflammation and pain in the eye.

Neuropathic corneal pain is a debilitating condition characterized by persistent, severe eye pain caused by nerve damage, impacting a significant number of patients worldwide. OKYO Pharma's urcosimod ...

DT-168 is a GeneTAC® small molecule, formulated as an eye drop, that is designed to selectively target the CTG repeat expansion in the TCF4 gene and reduce the expression of the mutant gene product ...